My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Addex Therapeutics Ltd - American Depositary Shares (NQ:ADXN)

8.940 -0.100 (-1.11%)
Streaming Delayed Price Updated: 11:29 AM EDT, Sep 26, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Addex Therapeutics Ltd - American Depositary Shares

< Previous 1 2 3 4 5 6 Next >
12 Health Care Stocks Moving In Friday's Intraday Session
 
Via Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
 
Via Benzinga
Why Adobe Shares Are Trading Higher By Over 4%; Here Are 20 Stocks Moving Premarket
 
Via Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
 
Via Benzinga
Earnings Scheduled For September 1, 2025
 
Via Benzinga
Earnings Scheduled For April 24, 2025
 
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
 
Via Benzinga
Earnings Scheduled For June 19, 2025
 
Via Benzinga
Earnings Scheduled For April 25, 2025
 
Via Benzinga
Earnings Scheduled For April 21, 2025
 
Via Benzinga
Earnings Scheduled For November 22, 2024
 
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
 
Via Benzinga
Why iRhythm Technologies Shares Are Trading Higher By Over 20%; Here Are 20 Stocks Moving Premarket
 
Via Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
 
Via Benzinga
S&P 500 Edges Higher; American Woodmark Shares Slide
 
Via Benzinga
Topics Stocks
Crude Oil Dips; Addex Therapeutics Shares Spike Higher
 
Via Benzinga
US Stocks Mixed; ScanSource Reports Weak Q4 Results
 
Via Benzinga
Johnson Johnson-Partner Addex Therapeutics Selects Investigational Compound For Substance Use Disorder
Addex Therapeutics stock surged after announcing clinical candidate selection with Indivior for substance use disorder treatment. Addex could receive up to $330 million plus royalties under the... 
Via Benzinga
Why Trip.com Group Shares Are Trading Higher By Around 10%; Here Are 20 Stocks Moving Premarket
 
Via Benzinga
After Disappointing Data, Johnson & Johnson Halts Developing Epilepsy Drug Candidate
Addex Therapeutics announces Janssen Pharmaceuticals, a Johnson & Johnson unit, has halted ADX71149 development for epilepsy after Phase 2 data. 
Via Benzinga
ADXN Stock Earnings: Addex Therapeutics Reported Results for Q1 2024
Addex Therapeutics just reported results for the first quarter of 2024. 
Via InvestorPlace
12 Health Care Stocks Moving In Monday's Pre-Market Session
 
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
It's time to dive into the biggest pre-market stock movers with all of the hottest news worth reading about on Monday morning! 
Via InvestorPlace
Why H&E Equipment Services Shares Are Trading Lower By Around 18%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
 
Via Benzinga
Why GeneDx Shares Are Trading Higher By 37%; Here Are 20 Stocks Moving Premarket
 
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
 
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
Our coverage for Tuesday starts with a dive into the biggest pre-market stock movers traders will want to keep an eye on today! 
Via InvestorPlace
S&P 500 Edges Higher; ON Semiconductor Earnings Top Views
 
Via Benzinga
Topics Stocks
Why Clever Leaves Holdings Shares Are Trading Lower By Around 60%? Here Are Other Stocks Moving In Monday's Mid-Day Session
 
Via Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
 
Via Benzinga
< Previous 1 2 3 4 5 6 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.